Esomeprazole and supplements: 3 sourced interactions

Proton pump inhibitor, also sold as Nexium and Nexium 24HR. Of these, 3 named by an FDA label or NIH page. Plus 1 food and drink line. Each links its source and the date it was checked.

A combination missing here is not on our list; that does not mean it is safe together.

Esomeprazole with supplements

Most serious first. Open a row for the mechanism, the source's words and the date checked.

Educational only. Check with your pharmacist or prescriber before changing anything you take.

Major

1
St John's wortLabel or NIHThe FDA label names this pair (breakdown by liver enzymes).

major · Named by an FDA label or NIH page · Breakdown by liver enzymes

In the source’s own words; rated major from that wording, not from a study of the pair.

“Avoid concomitant use of NEXIUM with St. John’s Wort or rifampin.”

“In a cross-over study in 12 healthy male subjects, St. John’s Wort (300 mg three times daily for 14 days) significantly decreased the systemic exposure of omeprazole in CYP2C19 poor metabolizers (Cmax and AUC both decreased by 38%) and extensive metabolizers (Cmax and AUC decreased by 50% and 44%, respectively) [see Drug Interactions (7)].”

“Decreased exposure of esomeprazole when used concomitantly with strong inducers [see Clinical Pharmacology (12.3)]. Intervention: St. John’s Wort, rifampin: Avoid concomitant use with”

  • FDA drug label (DailyMed) · NEXIUM (esomeprazole magnesium) delayed-release capsules and for delayed-release oral suspension, Rx, section 7
  • Checked Oct 23, 2026

Moderate

2
IronLabel or NIHThe FDA label names this pair (absorption in the gut).

moderate · Named by an FDA label or NIH page · Absorption in the gut

In the source’s own words; rated moderate from that wording, not from a study of the pair.

“Drugs Dependent on Gastric pH for Absorption (e.g., iron salts, erlotinib, dasatinib, nilotinib, mycophenolate mofetil, ketoconazole/itraconazole)”

“Drugs Dependent on Gastric pH for Absorption (e.g., iron salts, erlotinib, dasatinib, nilotinib, mycophenolate mofetil, ketoconazole/itraconazole) Clinical Impact: Esomeprazole can reduce the absorption of other drugs due to its effect on reducing intragastric acidity”

“Because proton pump inhibitors, such as lansoprazole (Prevacid) and omeprazole (Prilosec), reduce the acidity of stomach contents, they can reduce iron absorption”

  • FDA drug label (DailyMed) · NEXIUM (esomeprazole magnesium) delayed-release capsules and for delayed-release oral suspension, Rx, section 7
  • NIH Office of Dietary Supplements · Office of Dietary Supplements · Iron: Fact Sheet for Health Professionals, Interactions with Medications > Proton pump inhibitors
  • Checked Oct 23, 2026
MagnesiumLabel or NIHAn NIH page names this pair (cause not established).

moderate · Named by an FDA label or NIH page · Cause not established

In the source’s own words; rated moderate from that wording, not from a study of the pair.

“Prescription proton pump inhibitor (PPI) drugs, such as esomeprazole magnesium (Nexium) and lansoprazole (Prevacid), can cause hypomagnesemia when taken for prolonged periods (typically more than a year)”

  • NIH Office of Dietary Supplements · Office of Dietary Supplements · Magnesium: Fact Sheet for Health Professionals, Interactions with Medications > Proton pump inhibitors
  • Checked Oct 23, 2026

Esomeprazole with food and drink

Food and drink

1
GrapefruitPredictedGrapefruit may raise Esomeprazole levels: it slows CYP3A, an enzyme that breaks Esomeprazole down.

moderate · Predicted from how each works, not established · Breakdown by liver enzymes

Predicted from what each is known to do, not studied as a pair and not established.

Grapefruit may raise Esomeprazole levels: it slows CYP3A, an enzyme that breaks Esomeprazole down.

  • FDA table of drugs that interact with CYP enzymes · Grapefruit: CYP3A moderate inhibitor (Table 1, row "grapefruit juice", column "CYP Mod INH" (footnote 9: The effect of grapefruit juice varies widely among brands and is concentration-, dose-, and preparation-dependent. Studies have shown that it can be classified as a “strong CYP3A inhibitor” when a certain preparation was used (e.g., high dose, double strength) or more commonly as a “moderate CYP3A inhibitor” when another preparation was used (e.g., low dose, single strength).))
  • FDA drug label (DailyMed) · Esomeprazole: CYP3A substrate (NEXIUM (esomeprazole magnesium) delayed-release capsules and for delayed-release oral suspension, Rx, section 12.3 Pharmacokinetics · Metabolism)
  • Checked Oct 23, 2026

How these lines are sourced

Three kinds of line

  • Studied in people (PubMed): PubMed records that were opened and read, graded A (several controlled studies, or a finding in the dosing guidance), B (at least one controlled human study) or C (case reports, observational data or mechanism only).
  • Named by an FDA label or NIH page: quoted word for word from that page. Its severity comes from the source’s wording, not from a study of the pair.
  • Predicted from how each works, not established: built from sourced facts about each substance, such as the FDA’s table of enzyme roles. Never rated major.

Interaction MapCheck Esomeprazole with everything else you take, together

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.